What has SVE's performance been like?
Earnings is a powerful indication of SVE's ability to invest shareholders' funds and generate returns. Therefore I will use earnings as a proxy of Baxter's performance in the past year. Over the last year SVE released an earnings of UK£302.33K , which is an increase of 272.73% from its prior year's earnings of UK£81.11K. This could be a sign of a successful turnaround since SVE has not always been profitable, given its average EPS of -UK£0.013 over the past five years. As profits are moving up and up, CEO pay should echo Baxter's value creation for shareholders. During the same period, Baxter's total remuneration remained stable at UK£80.00K since the previous year.What's a reasonable CEO compensation?
Though no standard benchmark exists, since remuneration should be tailored to the specific company and market, we can determine a high-level benchmark to see if SVE deviates substantially from its peers. This outcome can help shareholders ask the right question about Baxter’s incentive alignment. On average, a UK small-cap is worth around £696M, generates earnings of £67M, and remunerates its CEO circa £1M per annum. Based on SVE's size and performance, in terms of market cap and earnings, it seems that Baxter is compensated similar to other comparable UK CEOs of profitable small-caps. This indicates that Baxter’s pay is fair.
Next Steps:
In the upcoming year's AGM, shareholders should think about whether another increase in CEO pay is justified, should the board propose an executive pay raise. Will this raise take Baxter's pay beyond the bound of reasonableness, or will it help in retaining the talented executive? Being proactive in governance decisions is a key part to investing, and collectively, investors can make a big difference. If you have not done so already, I highly recommend you to complete your research by taking a look at the following:
- 1. Governance: To find out more about SVE's governance, look through our infographic report of the company's board and management.
- 2. Financial Health: Does it have a healthy balance sheet? Take a look at our free balance sheet analysis with six simple checks on key factors like leverage and risk.
- 3. Other High-Growth Alternatives: Are there other high-growth stocks you could be holding instead of SVE? Explore our interactive list of stocks with large growth potential to get an idea of what else is out there you may be missing!
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
Simply Wall St analyst Simply Wall St and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
About AIM:SVE
Starvest
Starvest plc is a venture capital firm specializing in growth capital, early stage and mid stage investments, seed/startup, small company new issues, and pre-initial public offering opportunities.
Flawless balance sheet with weak fundamentals.
Market Insights
Community Narratives
